trending Market Intelligence /marketintelligence/en/news-insights/trending/Nd1DlvLfNEd92Bgh4lTtUw2 content esgSubNav
In This List

Neuren Pharmaceuticals director to retire

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Neuren Pharmaceuticals director to retire

Neuren Pharmaceuticals Ltd. said Larry Glass would retire from the company's board, effective Dec. 31.

The company said Glass would continue to serve as the company's chief scientific officer.

Australia's Neuren Pharmaceuticals develops therapies for brain injury, neurodevelopment and neurodegenerative disorders.